Skip to main content
. Author manuscript; available in PMC: 2010 May 6.
Published in final edited form as: Prostate. 2009 Mar 1;69(4):401–410. doi: 10.1002/pros.20895

Figure 5. Oct4A co-expression with differentiation markers for basal, luminal, and neuroendocrine lineages in human prostate tissue.

Figure 5

(A) Co-expression of Oct4A (Permanent red) and p63 (DAB); (B) Oct4A (DAB) and cytokeratin 5 (alexa 594); (C) Oct4A (Permanent red) and AR (DAB); (D) Oct4A (Permanent red) and PSA (DAB); (E) Oct4A (DAB) and chromogranin A (alexa 594); (F) Oct4A (Permanent red) and synaptophysin (DAB); (G) Oct4A (Permanent red) and bombesin (DAB); (H) Oct4A (Permanent red) and CD56 (DAB); (I) Oct4A (Permanent red) and nestin (DAB). Black bar: 10μM. Black arrows indicate Oct4A expression and blue arrows indicate expression of differentiation markers.